Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-10-28

Clinical Trial Update: Iron Replacement in Oesophagogastric Neoplasia [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 trial of iron replacement therapy for anemia in patients with esophageal or gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iron replacement therapy

Snippet

Sponsor: Nottingham University Hospitals NHS Trust | Conditions: Anemia, Esophageal Cancer | Phase 4 | Status: UNKNOWN